Michael Kluger

Dr. Michael Kluger

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2012 in Gastroenterology
Verified
Journal Article
Closed access
CDChristophe Duvoux
Christophe Duvoux
FRFrançoise Roudot–Thoraval
Françoise Roudot–Thoraval
TDThomas DECAENS
Thomas DECAENS
FPFabienne Pessione
Fabienne Pessione
HBHanaa Badran
Hanaa Badran
DCDaniel Cherqui
Daniel Cherqui

1 January 2019 in Annals of Surgery
Verified
Journal Article
Closed access
PDF file
BEBrett L. Ecker
Brett L. Ecker
MMMatthew T. McMillan
Matthew T. McMillan
VAValentina Allegrini
Valentina Allegrini
CBClaudio Bassi
Claudio Bassi
JBJoal D. Beane
Joal D. Beane
CVCharles M. Vollmer
Charles M. Vollmer
Objective: To identify a clinical fistula risk score following distal pancreatectomy. Background: Clinically relevant pancreatic fistula (CR-POPF) following distal pancreatectomy (DP) is a dominant contributor to procedural morbidity, yet risk factors attributable to CR-POPF and effective practices to reduce its occurrence remain elusive. Methods: This multinational, retrospective study of 2026 DPs involved 52 surgeons at 10 institutions (2001–2016). CR-POPFs were defined by 2016 International Study Group criteria, and risk models generated using stepwise logistic regression analysis were evaluated by c-statistic. Mitigation strategies were assessed by regression modeling while controlling for identified risk factors and treating institution. Results: CR-POPF occurred following 306 (15.1%) DPs. Risk factors independently associated with CR-POPF included: age (<60 yrs: OR 1.42, 95% CI 1.05–1.82), obesity (OR 1.54, 95% CI 1.19–2.12), hypoalbuminenia (OR 1.63, 95% CI 1.06–2.51), the absence of epidural anesthesia (OR 1.59, 95% CI 1.17–2.16), neuroendocrine or nonmalignant pathology (OR 1.56, 95% CI 1.18–2.06), concomitant splenectomy (OR 1.99, 95% CI 1.25–3.17), and vascular resection (OR 2.29, 95% CI 1.25–3.17). After adjusting for inherent risk between cases by multivariable regression, the following were not independently associated with CR-POPF: method of transection, suture ligation of the pancreatic duct, staple size, the use of staple line reinforcement, tissue patches, biologic sealants, or prophylactic octreotide. Intraoperative drainage was associated with a greater fistula rate (OR 2.09, 95% CI 1.51–3.78) but reduced fistula severity (P < 0.001). Conclusions: From this large analysis of pancreatic fistula following DP, CR-POPF occurrence cannot be reliably predicted. Opportunities for developing a risk score model are limited for performing risk-adjusted analyses of mitigation strategies and surgeon performance.

1 January 2013 in HPB
Verified
Journal Article
Open access
PDF file
RSRoberto Santambrogio
Roberto Santambrogio
MKMichael Kluger
Michael Kluger
MCMara Costa
Mara Costa
ABAndrea Belli
Andrea Belli
MBMatteo Barabino
Matteo Barabino
DCDaniel Cherqui
Daniel Cherqui
In 1996, the Barcelona group demonstrated the presence of clinically significant portal hypertension (PHTN), defined as a hepatic venous pressure gradient (HVPG) ≥ 10 mmHg, to be the most powerful predictor of post‐operative liver decompensation and, in a subsequent (1999) publication, of poor long‐term outcome in Child–Pugh A cirrhotic patients submitted to hepatic resection (HR).1. x 1. Bruix, J., Castells, A., Bosch, J., Feu, F., Fuster, J., and Garcia‐Pagan, J.C. Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Gastroenterology. 1996; 111: 1018–1022 Abstract | Full Text PDF | PubMed | Scopus (605) | Google Scholar See all References , 2. x 2. Llovet, J.M., Fuster, J., and Bruix, J. Intention‐to‐treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology. 1999; 30: 1434–1440 Crossref | PubMed | Scopus (1283) | Google Scholar See all References However, measurement of HVPG is invasive and requires technical expertise, whereas other clinical parameters are more easily evaluated.3 x 3. De Franchis, R., Dell'Era, A., and Primignani, M. Diagnosis and monitoring of portal hypertension. Dig Liver Dis. 2008; 40: 312–317 Abstract | Full Text | Full Text PDF | PubMed | Scopus (38) | Google Scholar See all References Indeed, the presence of oesophageal varices as determined by endoscopy or significant splenomegaly (major diameter >12 cm) with a platelet count of <100 000/mm3 are considered surrogate markers of clinically significant PHTN, regardless of portal pressure measurements.4 x 4. Bruix, J. and Sherman, M. Management of hepatocellular carcinoma. Hepatology. 2005; 42: 1208–1236 Crossref | PubMed | Scopus (4202) | Google Scholar See all References As a consequence of these studies, the European Association for the Study of the Liver (EASL) and American Association for the Study of Liver Diseases (AASLD) guidelines consider PHTN to be a relative contraindication to HR because of the high risk of post‐operative liver decompensation.4. x 4. Bruix, J. and Sherman, M. Management of hepatocellular carcinoma. Hepatology. 2005; 42: 1208–1236 Crossref | PubMed | Scopus (4202) | Google Scholar See all References , 5. x 5. Bruix, J. and Sherman, M. Management of hepatocellular carcinoma: an update. Hepatology. 2011; 53: 1020–1022 Crossref | PubMed | Scopus (4320) | Google Scholar See all References

29 December 2015 in Annals of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
MKMichael Kluger
Michael Kluger
IEIrene Epelboym
Irene Epelboym
BSBeth A. Schrope
Beth A. Schrope
KMKrishnaraj Mahendraraj
Krishnaraj Mahendraraj
EHElizabeth M. Hecht
Elizabeth M. Hecht
JCJohn A. Chabot
John A. Chabot

1 May 2015 in Journal of Hepatology
Verified
Journal Article
Closed access
MKMichael Kluger
Michael Kluger
JSJuan A. Salceda
Juan A. Salceda
ALAlexis Laurent
Alexis Laurent
CTClaude Tayar
Claude Tayar
CDChristophe Duvoux
Christophe Duvoux
DCDaniel Cherqui
Daniel Cherqui

12 October 2012 in Journal of Hepato-Biliary-Pancreatic Sciences
Verified
Journal Article
Open access
PDF file
MKMichael Kluger
Michael Kluger
Luca ViganòLuca Viganò
Luca Viganò
RBRyan Barroso
Ryan Barroso
DCDaniel Cherqui
Daniel Cherqui
Laparoscopic major hepatectomy remains a relatively rare operation because it is a difficult and technically demanding procedure, and a standard, safe, reproducible technique has not been widely adopted. This is compounded by “major hepatectomy” encompassing multiple different operations each with their own anatomic and procedural considerations. In 2010, we investigated our learning curve for laparoscopic liver resection. We found a significant increase in the number of major hepatectomies performed over a 12‐year period, with concurrent reductions in the use of hand‐assistance, pedicle clamping, median clamping time, median operative time, blood loss and morbidity. This learning curve was confirmed by a subsequent multinational study. Both hospital and surgeon volume have been shown to affect outcomes, and defining a sufficient number of repetitions before the learning curve plateaus is not easy for laparoscopic major hepatectomy. We recommend that laparoscopic competencies be developed upon a foundation of open liver surgery and that laparoscopic major hepatectomy should only be attempted after competency with less technically complex laparoscopic resections. A center advanced along its institutional learning curve provides the collective expertise necessary for safe patient selection and management. An environment with colleagues willing to share their acquired proficiency allows the surgeon to observe and critique his or her performance against colleagues. Also, the guidance of like‐minded surgeons supports technical development and improved outcomes. In conclusion, steady progress can be made along the learning curve through committed practice of increasingly complex tasks and with proper coaching in a high‐volume environment.